A Patient Diagnosed with POEMS Syndrome with Atypical Presentation

<p>POEMS syndrome is a paraneoplastic syndrome due to an underlying plasma cell neoplasm. The major criteria for the syndrome are polyradiculoneuropathy, clonal plasma cell disorder (PCD), sclerotic bone lesions, elevated vascular endothelial growth factor, and the presence of Castleman diseas...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Seyin Semiz H (Auteur), Sarıkaya O (Auteur), Duran M (Auteur), Ozsan N (Auteur), Saydam G (Auteur)
Formaat: Boek
Gepubliceerd in: Archives of Hematology Case Reports and Reviews - Peertechz Publications, 2018-06-19.
Onderwerpen:
Online toegang:Connect to this object online.
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_ahcrr_000011
042 |a dc 
100 1 0 |a Seyin Semiz H  |e author 
700 1 0 |a  Sarıkaya O  |e author 
700 1 0 |a  Duran M  |e author 
700 1 0 |a  Ozsan N  |e author 
700 1 0 |a Saydam G  |e author 
245 0 0 |a A Patient Diagnosed with POEMS Syndrome with Atypical Presentation 
260 |b Archives of Hematology Case Reports and Reviews - Peertechz Publications,   |c 2018-06-19. 
520 |a <p>POEMS syndrome is a paraneoplastic syndrome due to an underlying plasma cell neoplasm. The major criteria for the syndrome are polyradiculoneuropathy, clonal plasma cell disorder (PCD), sclerotic bone lesions, elevated vascular endothelial growth factor, and the presence of Castleman disease. Minor features include organomegaly, endocrinopathy, characteristic skin changes, papilledema, extravascular volume overload, and thrombocytosis [1]. Autologous Stem Cell Transplantation (ASCT) might be potential approach of choice in patients that are eligible; otherwise, systemic therapies adopted from the therapeutic armamentarium for multiple myeloma are alternatives [2]. İn this paper, we reported that a</p><p>patient which was treated with VAD (Vincristine, Doxorubicin, Dexamethasone 40 mg) with exlusion of vincristine due to existing neuropathy and ASCT with high-dose melphalan and improved; although the bone marrow biopsy did not observe a plasma cell clone.</p> 
540 |a Copyright © Seyin Semiz H et al. 
546 |a en 
655 7 |a Case Report  |2 local 
856 4 1 |u https://doi.org/10.17352/ahcrr.000011  |z Connect to this object online.